USPTO serial 88086496
GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Oct 6, 2020
- Examiner
- GANESH, HARINI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $548*
Plus Government fees of $850
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Limited
Mumbai, Maharashtra, IN
Other trademarks owned by Sun Pharmaceutical Industries Limited
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Keith Barritt
Keith Barritt FISH & RICHARDSON P.C.P.O. BOX 1022MINNEAPOLIS, MN 55440UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medicinal and pharmaceutical preparations packed in ready to use infusion bags for chemotherapy, reduction of tension and anxiety, improvement of heart function, correction of hemodynamic imbalances present in the shock syndrome, blood pressure control in certain acute hypotensive states and for intravenous induction of general anesthesia or before administration of other anesthetic, all of the foregoing comprising gemcitabine; medicinal and pharmaceutical preparations packed in ready to use infusion bags for treatment of cancer, pain, diseases related to central nervous system, epilepsy, ventricular tachycardia or ventricular fibrillation, irregular heartbeat, angina, blood pressure and gynecological disorders, all of the foregoing comprising gemcitabine | ACTIVE | Jul 8, 2020 |
| 010 | medical apparatus, namely, infusion devices for administering drugs in the nature of ready-to-use infusion bags containing medicinal and pharmaceutical preparations of gemcitabine | ACTIVE | Jul 8, 2020 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks owned by Sun Pharmaceutical Industries Limited
- Other trademarks in Class 005
- Other trademarks in Class 010
- Similar marks named GEMCITABINE IN 0.9% SODIUM CHLORIDE INJECTION 1,200 MG PER 120 ML (10 MG/ML)
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 6, 2025 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Oct 6, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Sep 3, 2020 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Sep 2, 2020 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Aug 13, 2020 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Aug 13, 2020 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Aug 4, 2020 | IUAF | USE AMENDMENT FILED | — |
| Aug 4, 2020 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Mar 20, 2020 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Mar 18, 2020 | EX2G | SOU EXTENSION 2 GRANTED | — |
| Mar 18, 2020 | EXT2 | SOU EXTENSION 2 FILED | — |
| Mar 18, 2020 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Sep 21, 2019 | EXRA | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | — |
| Sep 19, 2019 | EX1G | SOU EXTENSION 1 GRANTED | — |
| Sep 19, 2019 | EXT1 | SOU EXTENSION 1 FILED | — |
| Sep 19, 2019 | EEXT | SOU TEAS EXTENSION RECEIVED | The applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use. |
| Mar 26, 2019 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jan 29, 2019 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jan 29, 2019 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Jan 9, 2019 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Dec 21, 2018 | ALIE | ASSIGNED TO LIE | — |
| Nov 29, 2018 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 29, 2018 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 29, 2018 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2018 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 29, 2018 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Nov 27, 2018 | DOCK | ASSIGNED TO EXAMINER | — |
| Aug 30, 2018 | MDSM | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Aug 29, 2018 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 24, 2018 | NWAP | NEW APPLICATION ENTERED | — |